Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects

NCT02334501 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lansoprazole
DRUG: Neratinib

Sponsor

Puma Biotechnology, Inc.